CCND2 polymorphisms associated with clearance of HBV infection

Journal of Human Genetics

Volumn 55, Issue 7, 2010, Pages 416-420

  Park, Tae Joon ^a   Chun, Ji Yong ^a   Bae, Joon Seol ^a   Park, Byung Lae ^b   Cheong, Hyun Sub ^b   Lee, Hyo Suk ^c   Kim, Yoon Jun ^c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

cyclin D2; hepatitis B virus (HBV); hepatocellular carcinoma (HCC); liver cirrhosis (LC); polymorphism

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HAPLOTYPE MAP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS;

ADULT; AGE OF ONSET; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; CYCLIN D2; FEMALE; HAPLOTYPES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA;

HEPATITIS B VIRUS;

EID: 77954960905     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.36     Document Type: Article

References (21)

1. Lin, C. L. & Kao, J. H. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J. Biomed. Sci. 15, 137-145 (2008).
2. Lin, C. L., Liao, L. Y., Wang, C. S., Chen, P. J., Lai, M. Y., Chen, D. S. et al. Basal corepromoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int. 25, 564-570 (2005).
3. Park, B. L., Kim, Y. J., Cheong, H. S., Lee, S. O., Han, C. S., Yoon, J. H. et al. HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients. Biochem. Biophys. Res. Commun. 363, 776-781 (2007).
4. Shin, H. D., Park, B. L., Cheong, H. S., Yoon, J. H., Kim, Y. J. & Lee, H. S. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int. J. Epidemiol. 36, 1001-1008 (2007).
5. Shin, H. D., Park, B. L., Kim, L. H., Jung, J. H., Kim, J. Y., Yoon, J. H. et al. Interleukin haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 12, 901-906 (2003).
6. Kim, Y. J., Yoon, J. H., Kim, C. Y., Kim, L. H., Park, B. L., Shin, H. D. et al. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 346, 38-44 (2006).
7. Park, B. L., Kim, Y. J., Cheong, H. S., Kim, L. H., Choi, Y. H., Lee, H. S. et al. Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp. Mol. Med. 38, 694-702 (2006).
8. Kida, A., Kakihana, K., Kotani, S., Kurosu, T. & Miura, O. Glycogen synthase kinase- 3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasomedependent degradation in hematopoietic cells. Oncogene 26, 6630-6640 (2007).
9. Susaki, E., Nakayama, K. & Nakayama, K. I. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Mol. Cell. Biol. 27, 4626-4640 (2007).
10. Song, H., Hogdall, E., Ramus, S. J., Dicioccio, R. A., Hogdall, C., Quaye, L. et al. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin. Cancer. Res. 14, 1090-1095 (2008).
11. Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K. et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 35, 421-430 (2001).
12. Eberle, M. A. & Kruglyak, L. An analysis of strategies for discovery of single-nucleotide polymorphisms. Genet. Epidemiol. 19(Suppl 1), S29-S35 (2000).
13. Livak, K. J. Allelic discrimination using fluorogenic probes and the 5¢ nuclease assay. Genet. Anal. 14, 143-149 (1999).
14. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
15. Stephens, M., Smith, N. J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001).
16. Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74, 765-769 (2004).
17. Mermelshtein, A., Gerson, A., Walfisch, S., Delgado, B., Shechter-Maor, G., Delgado, J. et al. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br. J. Cancer. 93, 338-345 (2005).
18. Smith, L. Post-transcriptional regulation of gene expression by alternative 5¢-untranslated regions in carcinogenesis. Biochem. Soc. Trans. 36, 708-711 (2008).
19. Sergi, C., Arnold, J. C., Rau, W., Otto, H. F. & Hofmann, W. J. Single nucleotide insertion in the 5¢-untranslated region of hepatitis C virus with clearance of the viral RNA in a liver transplant recipient during acute hepatitis B virus superinfection. Liver 22, 79-82 (2002).
20. Choi, Y. L., Park, S. H., Jang, J. J. & Park, C. K. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma. J. Korean Med. Sci. 16, 424-432 (2001).
21. White, P. C., Shore, A. M., Clement, M., McLaren, J., Soeiro, I., Lam, E. W. et al. Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. Oncogene 25, 2170-2180 (2006).